Curis is a therapeutic drug development company. Its technology focus is on regulatory pathways that control repair and regeneration. Curis product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (in partnership with Genetech), kidney disease (in partnership with Ortho Biotech), neurological disorders (in partnership with Wyeth), hair growth (in partnership with Proctor & Gamble) and cardiovascular disease (in partnership with Internal Development).
Partial Data by Infogroup (c) 2024. All rights reserved.